Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
International Immunology|August 6, 2010
Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating diseaseNaoya Takeichi, Satoshi Yanagisawa, Tomoki Kaneyama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Gender bias in Theiler's virus-induced demyelinating disease correlates with the level of antiviral immune responsesAlyson C Fuller, Bongsu Kang, Hee Kap Kang, et al.
Journal of Neuroimmunology|January 18, 2014
Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating diseaseHiroki Tomiki, Tomoki Kaneyama, Kunitoshi Kobayashi, et al.
Journal of Autoimmunity|January 29, 2011
Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MSMaureen H Richards, Meghann Teague Getts, Joseph R Podojil, et al.
Journal of Neuroscience Research|January 27, 2007
Castration of male C57L/J mice increases susceptibility and estrogen treatment restores resistance to Theiler's virus-induced demyelinating diseaseAlyson Fuller, Hiroyuki Yahikozawa, Eui Young So, et al.
Journal of Neuroinflammation|September 19, 2012
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating diseaseByung S Kim, Young-Hee Jin, Liping Meng, et al.
Journal of Neuroimmunology|July 17, 2014
Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating diseaseSho Takizawa, Tomoki Kaneyama, Sayaka Tsugane, et al.
International Immunology|February 4, 2014
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating diseaseTomoki Kaneyama, Hiroki Tomiki, Sayaka Tsugane, et al.
Pageof 7